DMAC Operating Cash Flow (Statement)
Diamedica Therapeutics Inc · Operating Cash Flow (Statement)
DMAC Operating Cash Flow (Statement)
Latest reported-$31.57Mperiod ending
DMAC Cash from Operations (-$99.35K → -$31.57M)
Annual operating cash flow (statement)
High-resolution chart · PNG
DMAC operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -29,062,000 | |
| -22,076,000 | |
| -18,728,000 | |
| -11,511,000 | |
| -12,252,000 | |
| -9,185,000 | |
| -9,102,000 | |
| -5,696,000 | |
| -3,900,000 | |
| -3,023,179 | |
| -1,365,931 | |
| -3,755,675 | |
| -5,502,606 | |
| -5,483,825 | |
| -3,436,017 | |
| -2,376,769 | |
| -2,146,707 | |
| -1,466,355 | |
| -1,213,352 | |
| -801,159 | |
| -831,166 | |
| -99,354 |